BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220726T140000
DTEND;TZID=America/New_York:20220726T150000
DTSTAMP:20260405T182325
CREATED:20220719T152346Z
LAST-MODIFIED:20220719T152346Z
UID:2986-1658844000-1658847600@www.ctnnortheastnode.org
SUMMARY:Involving Families to Improve MOUD Adherence
DESCRIPTION:Presenter: Mark Fishman\, MD \nCost: No fee \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \n\n\n\nRegister now!
URL:https://www.ctnnortheastnode.org/event/involving-families-to-improve-moud-adherence/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220809T120000
DTEND;TZID=America/New_York:20220809T130000
DTSTAMP:20260405T182325
CREATED:20220802T162917Z
LAST-MODIFIED:20220802T162917Z
UID:3002-1660046400-1660050000@www.ctnnortheastnode.org
SUMMARY:American Youth Intentional Drug-Opioid Fatal Overdose: The Magnitude of the Problem and Improved Assessment of Intentionality
DESCRIPTION:Presenter: Yifrah Kaminer\, MD\, MBA\, Professor Emeritus\, Department of Psychiatry and Pediatrics\, Alcohol Research Center\, University of Connecticut School of Medicine \nSponsor: American Psychiatric Association (APA) \nCost: No Fee \nTarget audience: Psychiatrists\, physicians. The live webinar is accredited for physicians. \nCredit Designations Available: a maximum of 1.0 AMA PRA Category 1 Credit™ \nAbout the webinar: Dr. Kaminer presents the third webinar regarding youth/adolescent substance use disorder regards the epidemic of drug-related fatal overdoses among young people in the United States. Between 2000 and 2019\, the U.S. national suicide rate in youth aged 15 to 19 increased from 8 to 12.8 per 100\,000 and similarly\, in 20- to 24-year old’s from 12.5 to 17 per 100\,000. Due to difficulties assessing intentionality and differences among states\, the true rate of intentional drug-related fatal overdoses may not be known. This webinar aims to introduce the magnitude of the epidemic among youth in the United States\, as well as how this is a difficult health outcome to measure. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDescribe the complexities of assessing suicide intentionality.\nDiscuss child/adolescent substance use risk with patients and families.\nExplain how to conduct a brief psychological autopsy.\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/american-youth-intentional-drug-opioid-fatal-overdose-the-magnitude-of-the-problem-and-improved-assessment-of-intentionality/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220809T120000
DTEND;TZID=America/New_York:20220809T130000
DTSTAMP:20260405T182325
CREATED:20220808T174744Z
LAST-MODIFIED:20220808T174744Z
UID:3005-1660046400-1660050000@www.ctnnortheastnode.org
SUMMARY:American Youth Intentional Drug-Opioid Fatal Overdose: The Magnitude of the Problem and Improved Assessment of Intentionality
DESCRIPTION:Presenter: Yifrah Kaminer\, MD\, MBA\, Professor Emeritus\, Department of Psychiatry and Pediatrics\, Alcohol Research Center\, University of Connecticut School of Medicine \nSponsor: American Psychiatric Association (APA) \nCost: No Fee \nTarget audience: Psychiatrists\, physicians. The live webinar is accredited for physicians. \nCredit Designations Available: a maximum of 1.0 AMA PRA Category 1 Credit™ \nAbout the webinar: Dr. Kaminer presents the third webinar regarding youth/adolescent substance use disorder regards the epidemic of drug-related fatal overdoses among young people in the United States. Between 2000 and 2019\, the U.S. national suicide rate in youth aged 15 to 19 increased from 8 to 12.8 per 100\,000 and similarly\, in 20- to 24-year old’s from 12.5 to 17 per 100\,000. Due to difficulties assessing intentionality and differences among states\, the true rate of intentional drug-related fatal overdoses may not be known. This webinar aims to introduce the magnitude of the epidemic among youth in the United States\, as well as how this is a difficult health outcome to measure. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDescribe the complexities of assessing suicide intentionality.\nDiscuss child/adolescent substance use risk with patients and families.\nExplain how to conduct a brief psychological autopsy.\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/american-youth-intentional-drug-opioid-fatal-overdose-the-magnitude-of-the-problem-and-improved-assessment-of-intentionality-2/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220811T133000
DTEND;TZID=America/New_York:20220811T153000
DTSTAMP:20260405T182325
CREATED:20220711T202501Z
LAST-MODIFIED:20220711T202949Z
UID:2971-1660224600-1660231800@www.ctnnortheastnode.org
SUMMARY:A Conversation with NIH: Implementing the New Data Management and Sharing Policy (PART 1)
DESCRIPTION:REGISTER HERE for part 1 of this two-part webinar series. \nPresenter(s):\nTaunton Paine\, M.A.\, Director\, Scientific Data Sharing Policy Division\, NIH Office of Science Policy; Julia Slutsman\, Ph.D.\, Director\, Genomic Data Sharing Policy Implementation\, NIH Office of Extramural Research; Cindy Danielson\, Ph.D.\, Associate Director\, Systems Integration\, NIH Office of Extramural Research \nSchedule:\nPart 1: Thursday\, August 11\, 2022 / 1:30 – 3:30 PM EDT\nUnderstanding the New NIH Data Management and Sharing Policy \nPart 2: Thursday\, September 22\, 2022 / 1:30 – 3:30 PM EDT\nDiving Deeper into the new NIH Data Management and Sharing Policy \n 
URL:https://www.ctnnortheastnode.org/event/a-conversation-with-nih-implementing-the-new-data-management-and-sharing-policy/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220812T080000
DTEND;TZID=America/New_York:20220814T170000
DTSTAMP:20260405T182325
CREATED:20220727T220353Z
LAST-MODIFIED:20220727T220353Z
UID:2998-1660291200-1660496400@www.ctnnortheastnode.org
SUMMARY:The 2nd National Women and Addiction Group (WAG) Summit
DESCRIPTION:REGISTER TO ATTEND THIS SUMMIT HERE! \nThis year’s summit\, which will be held in-person with the opportunity for virtual attendance\, is titled “Compassionate Addiction Medicine: Whole Person Care for Birthing People”. \nJoin for an engaging community effort to improve non-judgmental\, trauma-responsive\, and whole person patient-centered care for mothers\, parents\, infants\, families\, and communities impacted by substance use disorder. \nBook your hotel room at the Sheraton Grand Seattle by July 8\, 2022 to secure the discounted room rate.
URL:https://www.ctnnortheastnode.org/event/the-2nd-national-women-and-addiction-group-wag-summit/
LOCATION:Seattle Convention Center
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220831T120000
DTEND;TZID=America/New_York:20220831T130000
DTSTAMP:20260405T182325
CREATED:20220817T180537Z
LAST-MODIFIED:20220817T180537Z
UID:3026-1661947200-1661950800@www.ctnnortheastnode.org
SUMMARY:Practitioner and Stakeholder Perspectives on Opioid Use and Treatment Across Rural Northern New England
DESCRIPTION:This presentation will explore data from UVM CORA’s Baseline Needs Assessments in Vermont\, New Hampshire\, and Maine\, sharing insights gathered from practitioners and stakeholders about their concerns about opioid use and their perceived barriers to and beliefs about opioid use disorder treatment. Learn what others in the field are saying! \nSpeakers:\nValerie Harder\, PhD\, MHS\, Associate Professor in the Departments of Pediatrics and Psychiatry and Co-Director of CORA’s Surveillance and Evaluation Core at the University of Vermont\nJulia Shaw\, MPH\, Manager of the Surveillance and Evaluation Core at UVM CORA \n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/practitioner-and-stakeholder-perspectives-on-opioid-use-and-treatment-across-rural-northern-new-england/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220906T110000
DTEND;TZID=America/New_York:20220906T170000
DTSTAMP:20260405T182325
CREATED:20220719T114437Z
LAST-MODIFIED:20220719T114710Z
UID:2983-1662462000-1662483600@www.ctnnortheastnode.org
SUMMARY:Prehospital Treatment for Opioid Use Disorder Virtual Workshop
DESCRIPTION:We are excited to announce that the National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual workshop titled “Prehospital Treatment for Opioid Use Disorder.” This workshop is scheduled for Tuesday\, September 6\, 2022 from 11:00 a.m.– 5:00 p.m. ET. An email will be sent to all registered attendees a few days before the meeting with the final agenda and list of speakers and panel participants. \n  \nThe NIDA CCTN is convening stakeholders\, experts\, and federal staff to present recent research and innovative EMS or paramedic administered approaches for opioid use disorder and overdose and to identify research needed to evaluate prehospital approaches for opioid use disorder. The meeting will highlight promising research\, describe innovative programs in the United States\, and identify research priorities to inform research planning. \n  \nIf you are interested\, please register for the meeting here. Once registered you will receive the Zoom information including an option to download a calendar invitation. If you have any questions about the meeting logistics\, please contact CTNSupport@leedmci.com. If you have any questions about this event\, please contact Dr. Kristen Huntley at kristen.huntley@nih.gov. \n  \nIndividuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event\, should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.
URL:https://www.ctnnortheastnode.org/event/prehospital-treatment-for-opioid-use-disorder-virtual-workshop/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220906T110000
DTEND;TZID=America/New_York:20220906T170000
DTSTAMP:20260405T182325
CREATED:20220811T183308Z
LAST-MODIFIED:20220811T183308Z
UID:3011-1662462000-1662483600@www.ctnnortheastnode.org
SUMMARY:"Prehospital Treatment for Opioid Use Disorder" Virtual Workshop
DESCRIPTION:REGISTER HERE! \nDescription: \nThe NIDA CCTN is convening stakeholders\, experts\, and federal staff to present recent research and innovative EMS or paramedic administered approaches for opioid use disorder and overdose and to identify research needed to evaluate prehospital approaches for opioid use disorder. The meeting will highlight promising research\, describe innovative programs in the United States\, and identify research priorities to inform research planning. \nOnce registered you will receive the Zoom information including an option to download a calendar invitation. \nIf you have any questions about the meeting logistics\, please contact CTNSupport@leedmci.com. If you have any questions about this event\, please contact Dr. Kristen Huntley at kristen.huntley@nih.gov. \nIndividuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event\, should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.
URL:https://www.ctnnortheastnode.org/event/prehospital-treatment-for-opioid-use-disorder-virtual-workshop-2/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220906T120000
DTEND;TZID=America/New_York:20220906T130000
DTSTAMP:20260405T182325
CREATED:20220831T200246Z
LAST-MODIFIED:20220831T200246Z
UID:3038-1662465600-1662469200@www.ctnnortheastnode.org
SUMMARY:Telehealth and Opioid Use Disorder
DESCRIPTION:Presenter: Marla Kushner\, DO \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/telehealth-and-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220908T143000
DTEND;TZID=America/New_York:20220908T153000
DTSTAMP:20260405T182325
CREATED:20220817T181043Z
LAST-MODIFIED:20220817T181043Z
UID:3029-1662647400-1662651000@www.ctnnortheastnode.org
SUMMARY:Mediators of Violence Exposure and Substance Use
DESCRIPTION:In this talk\, Trey Andrews\, PhD will discuss his project “Mediators of Violence Exposure and Substance Use (MoVES)”. MoVES is a RDAR Center funded project focused on delineating the exact pathways between specific substance use and violence-related factors to better understand the complexities of drug use and intelligently design interventions to reduce its harms. \nThis event is FREE and OPEN to the public. To register\, click the button below or use the following link: http://ow.ly/jBU950Kh2sc. \nCLICK HERE TO REGISTER
URL:https://www.ctnnortheastnode.org/event/mediators-of-violence-exposure-and-substance-use/
CATEGORIES:Other Related
ORGANIZER;CN="Rural Drug Addiction Research Center":MAILTO:rdar@unl.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220913T080000
DTEND;TZID=America/New_York:20220913T090000
DTSTAMP:20260405T182325
CREATED:20220720T184225Z
LAST-MODIFIED:20220720T184225Z
UID:2991-1663056000-1663059600@www.ctnnortheastnode.org
SUMMARY:Psychiatry Grand Rounds - Charles Brackett\, MD & Dana Pilchik\, PhD
DESCRIPTION:Charles Brackett\, MD & Dana Pilchik\, PhD \nPain in the Setting of Harmful Opioid Use \n  \nZoom link \nMeeting ID: 948 0596 9836 \nPasscode: 5555 \n  \nCME Credit information \nThose viewing Grand Rounds are now responsible for logging their attendance through this URL: https://dh.cloud-cme.com [nam12.safelinks.protection.outlook.com] \nYou can also log your credit using your phone by texting the activity code to (833)-884-3375 \n(this phone number will not change so if easiest\, you can program it into your phone under the name CME) \nCredit is only available for live participation and will not be awarded for past recordings. \n 
URL:https://www.ctnnortheastnode.org/event/psychiatry-grand-rounds-charles-brackett-md-dana-pilchik-phd/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220920T080000
DTEND;TZID=America/New_York:20220920T090000
DTSTAMP:20260405T182325
CREATED:20220720T184502Z
LAST-MODIFIED:20220720T184503Z
UID:2993-1663660800-1663664400@www.ctnnortheastnode.org
SUMMARY:Virtual Psychiatry Grand Rounds - Marley Doyle\, MD
DESCRIPTION:Marley Doyle\, MD \ntalk title TBA \n  \nZoom link \nMeeting ID: 948 0596 9836 \nPasscode: 5555 \n  \nCME Credit information \nThose viewing Grand Rounds are now responsible for logging their attendance through this URL: https://dh.cloud-cme.com [nam12.safelinks.protection.outlook.com] \nYou can also log your credit using your phone by texting the activity code to (833)-884-3375 \n(this phone number will not change so if easiest\, you can program it into your phone under the name CME) \nCredit is only available for live participation and will not be awarded for past recordings.
URL:https://www.ctnnortheastnode.org/event/virtual-psychiatry-grand-rounds-marley-doyle-md/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220921T120000
DTEND;TZID=America/New_York:20220921T130000
DTSTAMP:20260405T182325
CREATED:20220823T152340Z
LAST-MODIFIED:20220823T152340Z
UID:3035-1663761600-1663765200@www.ctnnortheastnode.org
SUMMARY:Contingency Management\, HIV\, and MSM: Current Status
DESCRIPTION:Our #VCBHLectureSeries is back! We are thrilled to kick off the FY23 season with guest speaker\, Steven Shoptaw\, PhD\, Executive Director of the Center for Behavioral and Addiction Medicine at UCLA. He will present\,” Contingency Management\, HIV\, and MSM: Current Status.” Dr. Shoptaw’s lecture is timely as we recognize Recovery Monthin September and look ahead to our 10th Annual Conference taking place October 6-7\, 2022 with a focus on contingency management. \nThis talk will provide an update on the status of evidence supporting use of contingency management for addiction treatment and harm reduction among men who have sex with men and for improving outcomes for HIV care and prevention. Attendees will understand the evidence describing outcomes when using contingency management for stimulant use disorders delivered in treatment and harm reduction settings for men who have sex with men. In addition\, learners will also understand the ways contingency management can be used to improve HIV care and prevention outcomes\, in primary care and specialty settings. \nSteven Shoptaw is a licensed psychologist and a professor in both the Department of Family Medicine and the Department of Psychiatry and Biobehavioral Sciences at UCLA. He is also an Honorary Professor at the University of Cape Town. For nearly 30 years\, Dr. Shoptaw has conducted a series of clinical studies in community clinic settings\, primarily on topics that involve developing and testing medical and behavioral interventions to treat substance use disorder and prevent the spread of HIV. He works with a broad spectrum of partners from university\, government and community settings. In addition\, he maintains a regular caseload of patients and provides training and mentorship to students and postdoctoral fellows. He was recently named Editor in Chief of the journal Drug and Alcohol Dependence. Dr. Shoptaw’s CV boasts more than 40 research grants and over 300 peer reviewed journal articles and book chapters. \n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/contingency-management-hiv-and-msm-current-status/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220922T133000
DTEND;TZID=America/New_York:20220922T153000
DTSTAMP:20260405T182325
CREATED:20220711T202840Z
LAST-MODIFIED:20220711T202901Z
UID:2977-1663853400-1663860600@www.ctnnortheastnode.org
SUMMARY:A Conversation with NIH: Implementing the New Data Management and Sharing Policy (PART 2)
DESCRIPTION:REGISTER HERE for part 2 of this two-part webinar series. \nPresenter(s):\nTaunton Paine\, M.A.\, Director\, Scientific Data Sharing Policy Division\, NIH Office of Science Policy; Julia Slutsman\, Ph.D.\, Director\, Genomic Data Sharing Policy Implementation\, NIH Office of Extramural Research; Cindy Danielson\, Ph.D.\, Associate Director\, Systems Integration\, NIH Office of Extramural Research \nSchedule:\nPart 1: Thursday\, August 11\, 2022 / 1:30 – 3:30 PM EDT\nUnderstanding the New NIH Data Management and Sharing Policy \nPart 2: Thursday\, September 22\, 2022 / 1:30 – 3:30 PM EDT\nDiving Deeper into the new NIH Data Management and Sharing Policy
URL:https://www.ctnnortheastnode.org/event/a-conversation-with-nih-implementing-the-new-data-management-and-sharing-policy-part-2/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220927T080000
DTEND;TZID=America/New_York:20220927T090000
DTSTAMP:20260405T182325
CREATED:20220720T184704Z
LAST-MODIFIED:20220720T184706Z
UID:2995-1664265600-1664269200@www.ctnnortheastnode.org
SUMMARY:Virtual Psychiatry Grand Rounds - Christopher Miller\, MD
DESCRIPTION:Christopher Miller\, MD \nDr. Miller is an orthopedic surgeon at Beth Israel Deaconess. \ntalk title TBA \n  \nZoom link \nMeeting ID: 948 0596 9836 \nPasscode: 5555 \n  \nCME Credit information \nThose viewing Grand Rounds are now responsible for logging their attendance through this URL: https://dh.cloud-cme.com [nam12.safelinks.protection.outlook.com] \nYou can also log your credit using your phone by texting the activity code to (833)-884-3375 \n(this phone number will not change so if easiest\, you can program it into your phone under the name CME) \nCredit is only available for live participation and will not be awarded for past recordings.
URL:https://www.ctnnortheastnode.org/event/virtual-psychiatry-grand-rounds-christopher-miller-md/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220929T103000
DTEND;TZID=America/New_York:20220929T163000
DTSTAMP:20260405T182325
CREATED:20220816T161557Z
LAST-MODIFIED:20220816T161557Z
UID:3021-1664447400-1664469000@www.ctnnortheastnode.org
SUMMARY:“Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment" Virtual Workshop
DESCRIPTION:REGISTER HERE! \nDescription: \nObservational research and digital health studies have made significant progress in recent years\, including target trial emulations using real-world data (RWD) and translational testing of digital health tools in real-world settings. This workshop aims to introduce these trending approaches; assess their strengths\, limitations\, and potential; discuss feasible research questions; identify study priorities\, and explore actionable strategies to address barriers and challenges for advancing substance use disorder (SUD) research. \nOnce registered you will receive the Zoom information including an option to download a calendar invitation. \nIf you have any questions about the meeting logistics\, please contact CTNSupport@leedmci.com. If you have any questions about this event\, please contact Dr. Xiaoming Wang at xiaoming.wang@nih.gov. \nIndividuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event\, should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event. \n 
URL:https://www.ctnnortheastnode.org/event/target-trial-emulation-in-observational-research-and-translational-testing-of-advanced-digital-health-tools-for-sud-prevention-and-treatment-virtual-workshop/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220929T103000
DTEND;TZID=America/New_York:20220929T163000
DTSTAMP:20260405T182325
CREATED:20220908T010803Z
LAST-MODIFIED:20220908T010920Z
UID:3040-1664447400-1664469000@www.ctnnortheastnode.org
SUMMARY:Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment
DESCRIPTION:REGISTER HERE! \nDescription: \nThis workshop aims to introduce these trending approaches; assess their strengths\, limitations\, and potential; discuss feasible research questions; identify study priorities\, and explore actionable strategies to address barriers and challenges for advancing substance use disorder (SUD) research. \nMeeting Chair: Lisa Marsch\, Ph.D. – Dartmouth College \nThe workshop consists of three subthemes with the following speakers:\nLearning Real-World Evidence of SUD from Nationwide Data Sources\nChristopher Jones\, Pharm.D.\, Dr.PH.\, M.P.H. – Centers for Disease Control and Prevention\nBeth Han\, M.D.\, Ph.D.\, M.P.H. – National Institute on Drug Abuse\, National Institutes of Health\nJulie Donohue\, Ph.D. – University of Pittsburgh \nTarget Trial Emulation in Observational Research\nSara Lodi\, Ph.D. – Boston University\nRolf Groenwold\, Ph.D. – Leiden University\, Netherlands\nJoshua Wallach\, Ph.D. M.S. – Yale University\nMarc LaRochelle\, M.D.\, M.P.H. – Boston University \nTranslational Testing of Clinical- and Community-Based Digital Health Systems\nBrandon Marshall\, Ph.D. – Brown University\nRebecca Rossom\, M.D.\, M.S. – HealthPartners\nJenny Lo-Ciganic\, Ph.D.\, M.S.Pharm. – University of Florida\nWalid Gellad\, M.D.\, M.P.H. – University of Pittsburgh\nMajid Afshar\, M.D.\, MSCR – University of Wisconsin-Madison \nOnce registered\, you will receive the Zoom information\, including an option to download a calendar invitation. If you have any questions about the meeting logistics\, please contact CTNSupport@leedmci.com. If you have any questions about this event\, please contact Dr. Xiaoming Wang at xiaoming.wang@nih.gov. \nIndividuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.
URL:https://www.ctnnortheastnode.org/event/target-trial-emulation-in-observational-research-and-translational-testing-of-advanced-digital-health-tools-for-sud-prevention-and-treatment/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221006
DTEND;VALUE=DATE:20221008
DTSTAMP:20260405T182325
CREATED:20220810T180210Z
LAST-MODIFIED:20220810T180210Z
UID:3008-1665014400-1665187199@www.ctnnortheastnode.org
SUMMARY:Annual VCBH Conference: Contingency Management for Increasing Abstinence  from Substance Use and Promoting Health in Vulnerable Populations
DESCRIPTION:After holding our past two conferences fully remote\, we are excited to offer a hybrid conference for the first time. We will be returning to our location at the Hilton Burlington Lake Champlain for those that enjoy the experience of connecting in person and love coming to Vermont in the fall. A virtual option is available for those unable to attend in person. \nProof of vaccination is required at registration on site. We are following Vermont State Health Department guidance for our conference and ask that you consider wearing a mask. If any guidance changes prior to our conference\, we will make all necessary adjustments. \nWe are at a pivotal time for contingency management (CM) in the US. This fall\, California will become the first state in the country to launch a pilot program of CM with a Medicaid benefit. We will have speakers specifically discussing the California program and key implementation issues\, legal implications\, and the application and advancement of contingency management in various health areas including substance use disorder\, tobacco cessation\, and cardiac rehabilitation. Speakers include: \n\nKen Silverman\, PhD: Keynote\nBarbara Andraka-Christou\, PhD\, JD\nSara Becker\, PhD\nH. Westley Clark\, MD\, MPH\, JD\nThomas E. Freese\, PhD\nMichael G. McDonnell\, PhD\n\nAttend In Person – Options for in-person attendance include: \n\nattend both Oct 6th and 7th\nattend Oct 6th only\nattend Oct 7th only\n\nAttend Virtually \nAttend our entire conference virtually from the comfort of your home or office. Or\, maybe you can only attend one day in person and need to attend one day virtually. \nRegister Now
URL:https://www.ctnnortheastnode.org/event/annual-vcbh-conference-contingency-management-for-increasing-abstinence-from-substance-use-and-promoting-health-in-vulnerable-populations/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221013T143000
DTEND;TZID=America/New_York:20221013T153000
DTSTAMP:20260405T182325
CREATED:20220817T181305Z
LAST-MODIFIED:20220817T181305Z
UID:3032-1665671400-1665675000@www.ctnnortheastnode.org
SUMMARY:What has Brain Imaging Taught us about Addiction?
DESCRIPTION:Edythe London\, PhD will be joining us to discuss how the imaging of brain structure\, chemistry and function is possible using noninvasive techniques that have been applied to the study of addiction. She will cover how it is possible to identify regional and circuit-level abnormalities that maintain drug misuse and promote a return to drug use after the initiation of abstinence. \nThis event is FREE and OPEN to the public. To register\, click the button below or use the following link: http://ow.ly/wZam50Kh11p. \n\n\n\nCLICK HERE TO REGISTER
URL:https://www.ctnnortheastnode.org/event/what-has-brain-imaging-taught-us-about-addiction/
CATEGORIES:Other Related
ORGANIZER;CN="Rural Drug Addiction Research Center":MAILTO:rdar@unl.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221019T123000
DTEND;TZID=America/New_York:20221019T133000
DTSTAMP:20260405T182325
CREATED:20221012T122957Z
LAST-MODIFIED:20221012T122957Z
UID:3050-1666182600-1666186200@www.ctnnortheastnode.org
SUMMARY:The Neurobiology of Addiction
DESCRIPTION:Presenter: Steven Straubing\, MD \nCost: No fee \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \n  \nRegister now!
URL:https://www.ctnnortheastnode.org/event/the-neurobiology-of-addiction/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221024T170000
DTEND;TZID=America/New_York:20221024T190000
DTSTAMP:20260405T182325
CREATED:20221017T162524Z
LAST-MODIFIED:20221017T162524Z
UID:3054-1666630800-1666638000@www.ctnnortheastnode.org
SUMMARY:Overdose Prevention and Harm Reduction: The Fundamentals of Addiction Medicine ECHO Session 1
DESCRIPTION:Register Now\n\n\n\nPresenters: J. Deanna Wilson\, MD\, MPH; Abby Letcher\, MD\, FASAM; Angela Colistra\, PhD\, LPC\, CAADC\, CCS; and Shanna Diaz\, DO \nSeries: The Fundamentals of Addiction Medicine ECHO (FAME) series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. Upon completion\, you will be able to utilize new skills and strategies to help you improve care for patients with addiction. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for On-Demand. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: This activity is designed for physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. This activity is accredited for physicians. \nCredit designations available: 2 AMA PRA Category 1 Credits™ \nWebinar Description: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nEducational Objectives: \n\nDevelop a community of mentors and colleagues to support professional development and build confidence in providing best practices in patient care for patients with addiction.\nAnalyze real patient cases to identify barriers to treatment and discuss solutions to overcome those barriers to ensure best evidence-based treatment options\, including pharmacological and non-pharmacological treatment\, for patients with addiction.\nDemonstrate professionalism in all interactions with patients and professional colleagues and demonstrate a commitment to the health and well-being of individuals and society through ethical practice\, profession-led regulation\, and high personal standards of behavior.\n\nContinuing Education information: \nACCME Accreditation Statement \nThe American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nAMA Credit Designation Statement \nThe American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \n  \n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/overdose-prevention-and-harm-reduction-the-fundamentals-of-addiction-medicine-echo-session-1/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221107T170000
DTEND;TZID=America/New_York:20221107T190000
DTSTAMP:20260405T182325
CREATED:20221031T115417Z
LAST-MODIFIED:20221031T115417Z
UID:3073-1667840400-1667847600@www.ctnnortheastnode.org
SUMMARY:Behavioral Interventions Integration of Skills into Addiction Medical Visits
DESCRIPTION:Register Now \nPresenters: Trina Fullard\, MA\, CCS\, LCAS; Abby Letcher\, MD\, FASAM; Angela Colistra\, PhD\, LPC\, CAADC\, CCS; and Shanna Diaz\, DO \nSeries: The Fundamentals of Addiction Medicine ECHO (FAME) series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. Upon completion\, you will be able to utilize new skills and strategies to help you improve care for patients with addiction. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for On-Demand. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: This activity is designed for physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. This activity is accredited for physicians. \nCredit designations available: 2 AMA PRA Category 1 Credits™ \nWebinar Description: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nEducational Objectives: \n\nDevelop a community of mentors and colleagues to support professional development and build confidence in providing best practices in patient care for patients with addiction.\nAnalyze real patient cases to identify barriers to treatment and discuss solutions to overcome those barriers to ensure best evidence-based treatment options\, including pharmacological and non-pharmacological treatment\, for patients with addiction.\nDemonstrate professionalism in all interactions with patients and professional colleagues and demonstrate a commitment to the health and well-being of individuals and society through ethical practice\, profession-led regulation\, and high personal standards of behavior.\n\nContinuing Education information: \nACCME Accreditation Statement \nThe American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nAMA Credit Designation Statement \nThe American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nRegister Now
URL:https://www.ctnnortheastnode.org/event/behavioral-interventions-integration-of-skills-into-addiction-medical-visits/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221130T120000
DTEND;TZID=America/New_York:20221130T130000
DTSTAMP:20260405T182325
CREATED:20221121T155703Z
LAST-MODIFIED:20221121T155703Z
UID:3097-1669809600-1669813200@www.ctnnortheastnode.org
SUMMARY:Applying Motivation-Phase Interventions to Treat Tobacco Use Among People with Opioid Use Disorder
DESCRIPTION:Register Now\n\nThis presentation will cover the importance of tobacco treatment for people with opioid use disorder and discuss research on providing treatment for smokers who are not motivated or not ready to quit. Lack of motivation or readiness to quit in the near future is a common barrier for tobacco use disorder and will be explored with a specific focus on those who live in rural communities. Register and attend to learn more!\nSpeaker:\nElias Klemperer\, PhD\, Associate Professor at the University of Vermont in the Departments of Psychiatry and Psychological Science and an investigator with the Vermont Center on Behavior and Health\n\n\n\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/applying-motivation-phase-interventions-to-treat-tobacco-use-among-people-with-opioid-use-disorder/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221201T160000
DTEND;TZID=America/New_York:20221201T170000
DTSTAMP:20260405T182325
CREATED:20221130T155207Z
LAST-MODIFIED:20221130T155207Z
UID:3103-1669910400-1669914000@www.ctnnortheastnode.org
SUMMARY:Suicide and Opioids: Intersections and Opportunities for Prevention
DESCRIPTION:Register Now\n\n\n\nPresenter: Ellyson Stout\, MS\, US Director of Community Suicide Prevention\, Education Development Center (EDC) \nSponsor: National Council for Mental Wellbeing–NCMW \n  \nTarget Audience: This activity is designed for mental health and addiction treatment professionals\, integrated care providers\, and medical staff. This activity is accredited for nurses\, physicians\, physician assistants\, social workers\, pharmacists\, interprofessional teams and other health professionals. \nAbout the webinar: Suicide is a leading cause of death in the United States\, with provisional estimates of over 47\,000 deaths in 2021. Nonetheless\, the evidence shows suicide can be prevented through comprehensive healthcare and community-based strategies\, as outlined in the Surgeon General’s Call to Action to Implement the National Strategy for Suicide Prevention. Substance misuse is a risk factor for suicide\, and people who use opioids are at increased risk for suicidal thoughts and behaviors. This webinar will provide an overview of risk and protective factors associated with suicidality and opioid use disorder (OUD)\, and will outline effective organizational and clinical prevention and intervention strategies for individuals experiencing OUD. \nEducational objectives: \n\nDescribe the broad context of suicide in the U.S. and what we know about suicide prevention.\nExamine the relationship between suicidality and opioid use disorder (OUD) from a public health standpoint.\nLeverage clinical intervention and prevention strategies and resources to address suicidality and OUD.\n\n\n\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/suicide-and-opioids-intersections-and-opportunities-for-prevention/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221206T130000
DTEND;TZID=America/New_York:20221206T140000
DTSTAMP:20260405T182325
CREATED:20221130T192244Z
LAST-MODIFIED:20221130T192244Z
UID:3106-1670331600-1670335200@www.ctnnortheastnode.org
SUMMARY:Utilizing Passively Collected Data in Daily Life to Enhance the Assessment and Treatment of Mental Health
DESCRIPTION:Register via Zoom \nDr. Nick Jacobson is a tenure-track assistant professor in the departments of Biomedical Data Science and Psychiatry within the Center for Technology and Behavioral Health in the Geisel School of Medicine at Dartmouth College. He directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory. Dr. Jacobson researches the use of technology to enhance both the assessment and treatment of anxiety and depression. His work has focused on (1) enhancing precision assessment of anxiety and depression using intensive longitudinal data\, (2) conducting multimethod assessment utilizing passive sensor data from smartphones and wearable devices\, and (3) providing scalable\, personalized technology-based treatments utilizing smartphones. He has a strong interest in creating personalized just-in-time adaptive interventions and the quantitative tools that make this work possible. To date\, Dr. Jacobson’s smartphone applications which assess and treat anxiety and depression have been downloaded and installed by more than 50\,000 people in over 100 countries. Dr. Jacobson is the principal investigator of an R01 Awarded from the National Institute of Mental Health studying the use of personalized deep learning models to predict rapid changes in major depressive disorder symptoms using passive sensor data from smartphones and wearable devices. \nRegister via Zoom
URL:https://www.ctnnortheastnode.org/event/utilizing-passively-collected-data-in-daily-life-to-enhance-the-assessment-and-treatment-of-mental-health/
CATEGORIES:Other Related
ORGANIZER;CN="Center for Behavioral Intervention Technologies":MAILTO:cbits@northwestern.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230111T120000
DTEND;TZID=America/New_York:20230111T130000
DTSTAMP:20260405T182325
CREATED:20221221T150930Z
LAST-MODIFIED:20221221T150930Z
UID:3123-1673438400-1673442000@www.ctnnortheastnode.org
SUMMARY:Recommendations for Culturally Recentering Reinforcement-Based Substance Use Disorder Interventions in Collaboration with Rural Tribal Communities
DESCRIPTION:This presentation will cover ways to culturally adapt and implement contingency management among rural American Indian and Alaska Native communities. This will be achieved by describing evidence around substance use disorder (SUD) in rural American Indian and Alaska Native communities\, discussing the importance of cultural adaptation for SUD treatment among members of rural Tribal communities\, and defining reinforcement-based SUD interventions. Register to learn more! \nSpeaker:\nKait Hirchak\, PhD\, MHPA (Eastern Shoshone)\, Assistant Professor at the Elson S. Floyd College of Medicine\, Washington State University \nRegister Now
URL:https://www.ctnnortheastnode.org/event/recommendations-for-culturally-recentering-reinforcement-based-substance-use-disorder-interventions-in-collaboration-with-rural-tribal-communities/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230118T120000
DTEND;TZID=America/New_York:20230118T130000
DTSTAMP:20260405T182325
CREATED:20230118T131550Z
LAST-MODIFIED:20230118T131550Z
UID:3191-1674043200-1674046800@www.ctnnortheastnode.org
SUMMARY:Tobacco Regulations Across the Continuum of Harm
DESCRIPTION:Tracy Smith\, PhD \nAssistant Professor of Psychiatry and Behavioral Services \nMedical University of South Carolina \n  \nThe VCBH Monthly Lecture Series was originally created as an in-person series designed as a way to interact and engage with top researchers in the intersectional fields we often work with at VCBH including behavior change\, addiction\, chronic disease\, and health disparities for people who are at increased risk. Following the COVID-19 pandemic\, the VCBH made remote viewing available for the lecture series. While we are now moving back to in-person presentations at the UVM Medical Center\, remote attendees can still view this presentation via Zoom. If you wish to attend remotely\, please register through the link below. \n  \n\n\n\nRemote Registration
URL:https://www.ctnnortheastnode.org/event/tobacco-regulations-across-the-continuum-of-harm/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230123T170000
DTEND;TZID=America/New_York:20230123T190000
DTSTAMP:20260405T182325
CREATED:20230116T171427Z
LAST-MODIFIED:20230116T171427Z
UID:3186-1674493200-1674500400@www.ctnnortheastnode.org
SUMMARY:Alcohol Use Disorder (FAME Session #3)
DESCRIPTION:Presenters: Abby Letcher\, MD\, FASAM; Angela Colistra\, PhD\, LPC\, CAADC\, CCS; Shanna Diaz\, DO \nSeries: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for on-demand viewing. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: This activity is designed for physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. This activity is accredited for physicians. \nCredit designations available: 2 AMA PRA Category 1 Credits™ \nEducational Objectives: Upon completion\, learners will be able to: \n\nDevelop a community of mentors and colleagues to support professional development and build confidence in providing best practices in patient care for patients with addiction.\nAnalyze real patient cases to identify barriers to treatment and discuss solutions to overcome those barriers to ensure best evidence-based treatment options\, including pharmacological and non-pharmacological treatment\, for patients with addiction.\nDemonstrate professionalism in all interactions with patients and professional colleagues and demonstrate a commitment to the health and well-being of individuals and society through ethical practice\, profession-led regulation\, and high personal standards of behavior.\n\nRegister Now \nQuestions about registering should be directed to: ASAM Education by email ateducation@asam.org
URL:https://www.ctnnortheastnode.org/event/alcohol-use-disorder-fame-session-3/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230124T130000
DTEND;TZID=America/New_York:20230124T140000
DTSTAMP:20260405T182325
CREATED:20230120T224539Z
LAST-MODIFIED:20230120T224539Z
UID:3194-1674565200-1674568800@www.ctnnortheastnode.org
SUMMARY:The Connection Between Mental Health and Opioid Use Disorder
DESCRIPTION:Presenter: Mark Duncan\, MD\, Assistant Professor\, University of Washington\, Director\, UW Psychiatry and Addictions Case Conference \nSponsor: American Psychiatric Association (APA) \nCost: No Fee \nTarget audience: Physicians\, nurse practitioners or other advanced practice nurses\, PAs\, social workers\, pharmacists\, and healthcare teams \nCredit Designations Available: AAPA Category 1 CME\, Social Work CE Credit\, Nursing Contact Hours\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: There is a high prevalence of mental health disorders among those with opioid use disorder. However\, many practitioners still find it difficult to distinguish between differential diagnoses that may have similar symptomatology\, especially in regards to mental health and substance misuse. This webinar will enable participants to summarize the prevalence of common co-morbid mental illness\, explain the relationships between concurrent mental health and opioid use disorder (OUD) and recognize risk factors associated with both mental health disorders and OUD. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nSummarize the prevalence of common co-morbid mental health (MH) disorders.\nExplain genetic and environmental relationship between concurrent MH disorders and Opioid Use Disorder (OUD).\nDescribe the impact that co-occurring MH and OUD can have on treatment of both.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/the-connection-between-mental-health-and-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230208T120000
DTEND;TZID=America/New_York:20230208T130000
DTSTAMP:20260405T182325
CREATED:20230202T151257Z
LAST-MODIFIED:20230202T151257Z
UID:3196-1675857600-1675861200@www.ctnnortheastnode.org
SUMMARY:Comparing Methods of Buprenorphine Treatment Initiation in Patients Using Fentanyl
DESCRIPTION:Presenter: Adam Bisaga\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nThis talk discusses substance use disorder treatment in a post-COVID world. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/comparing-methods-of-buprenorphine-treatment-initiation-in-patients-using-fentanyl/
CATEGORIES:Other Related
END:VEVENT
END:VCALENDAR